Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... with developmental disabilities. The company has made a commitment to the Susan G. Komen Breast Cancer Foundation and contributes to the cause."My goal is to offer American-made ...
2009 NOV 24 ... and colleagues.The researchers concluded: "The methods are applied to a breast cancer data set with gene expression recordings and to the primary biliary cirrhosis clinical ...
2009 NOV 29 ... in patients who were 65 years or older and diagnosed with colon, non-small cell lung, or breast cancer or diffuse large B-cell lymphoma in 1991-2002. Patients were identified in the ...
2009 NOV 29 ... eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis.Published in this week's (Nov. 9) Proceedings of the ...
2009 NOV 24 ... (MRI) instrument for breast MRI, like mammogram, which provides early diagnosis of breast cancer at very early stage to save lives of many ill women. Gene and Olivia, both originally ...
2009 NOV 25 ... the field-of-view and the overall detection sensitivity and minimized the undetected breast region near the chest wall," wrote R.A. Ramirez and colleagues, University of ... additional information, contact R.A. Ramirez, University of Texas Houston, MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.Publisher contact ...
2009 NOV 23 ... factor-related apoptosis-inducing ligand (TRAIL) and adriamycin (ADM) on the human breast cancer cell line MCF-7 and to identify potential mechanisms of apoptosis. Cell viability was ...
2009 NOV 23 ... New research, 'The economic consequences of breast cancer adjuvant hormonal treatments,' is the subject of a report. "Adjuvant hormone therapy ...
2009 NOV 23 ... According to recent research published in the journal Breast Cancer Research and Treatment, "The p53 tumor suppressor gene has a central role in the ...
2009 NOV 23 ... (N=109 survivors and 641 noncancer patients). Patient self-reported screening rates for breast cancer (72%), colorectal cancer (81%) and prostate cancer (77%) were higher for cancer ...
2009 NOV 23 ... Keywords: City:Providence, State:RI, Country:United States, Behavioral Science, Breast Cancer Screening, Breast Carcinoma Screening, Oncology, Women's Health, Brown University. ...
2009 NOV 23 ... According to a study from the United States, "HER2 amplification in breast cancer is associated with a more aggressive disease, greater likelihood of recurrence, and ...
2009 NOV 23 ... "Estrogen plus progestin therapy increases breast cancer incidence and breast tenderness. Whether breast tenderness during estrogen plus ...
2009 NOV 23 ... in 'The potential of survivorship care plans in primary care follow-up of minority breast cancer patients' new findings in breast cancer. "When the ...
2009 NOV 23 ... Larry Norton. The Company expects to initiate a Phase I/II study of oral indibulin in breast cancer patients employing this dosing schedule established preclinically. Once the maximum ...
2009 NOV 23 ... Oral indibulin (ZybulinTM or ZIO-301) is scheduled to enter into a Phase I/II study in breast cancer patients using the Norton-dosing schedule developed preclinically with Dr. Larry Norton ...
